These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15478074)

  • 61. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
    HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients.
    García de Olalla P; Martínez-González MA; Caylà JA; Jansà JM; Iglesias B; Guerrero R; Marco A; Gatell JM; Ocaña I;
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1051-7. PubMed ID: 12546112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania.
    van den Broek J; Mfinanga S; Moshiro C; O'Brien R; Mugomela A; Lefi M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):547-52. PubMed ID: 9661820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients.
    Pulido F; Peña JM; Rubio R; Moreno S; González J; Guijarro C; Costa JR; Vázquez JJ
    Arch Intern Med; 1997 Jan; 157(2):227-32. PubMed ID: 9009982
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment.
    Bottieau E; Noë A; Florence E; Colebunders R
    Infection; 2003 Mar; 31(2):118-20. PubMed ID: 12682819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
    Kerkhoff AD; Wood R; Lawn SD
    AIDS; 2011 Apr; 25(7):1003-6. PubMed ID: 21346513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?
    Kerbiriou L; Ustianowski A; Johnson MA; Gillespie SH; Miller RF; Lipman MC
    Clin Infect Dis; 2003 Nov; 37(9):1250-4. PubMed ID: 14557971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru.
    Shin S; Muñoz M; Espiritu B; Zeladita J; Sanchez E; Callacna M; Rojas C; Arevalo J; Wu Y; Caldas A; Sebastian JL
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(2):74-81. PubMed ID: 18319510
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.
    Narendran G; Menon PA; Venkatesan P; Vijay K; Padmapriyadarsini C; Ramesh Kumar S; Bhavani KP; Sekar L; Gomathi SN; Chandrasekhar C; Kumar S; Sridhar R; Swaminathan S
    Clin Infect Dis; 2014 Dec; 59(12):1798-804. PubMed ID: 25156114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
    Vaccher E; Spina M; Talamini R; Zanetti M; di Gennaro G; Nasti G; Tavio M; Bernardi D; Simonelli C; Tirelli U
    Clin Infect Dis; 2003 Dec; 37(11):1556-64. PubMed ID: 14614680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Preliminary study of the Th17/Treg immunoregulation in patients coinfected with TB and HIV before and after HAART].
    Liu YX; Yang GL; Zhou Y; Zhang HM; Zhang JY; Wang SY; Liu Y; Liu ST; Zhang LK; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):348-50. PubMed ID: 22338221
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Tuberculosis and HIV co-infection: a therapeutic challenge].
    Charbonnier F; Calmy A; Janssens JP
    Rev Med Suisse; 2011 Nov; 7(318):2295-6, 2298-300. PubMed ID: 22400365
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
    D'Jaen GA; Pantanowitz L; Bower M; Buskin S; Neil N; Greco EM; Cooley TP; Henry D; Stem J; Dezube BJ; Stebbing J; Aboulafia DM
    Clin Lung Cancer; 2010 Nov; 11(6):396-404. PubMed ID: 21062730
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.
    Sharma SK; Dhooria S; Barwad P; Kadhiravan T; Ranjan S; Miglani S; Gupta D
    Indian J Med Res; 2010 Jun; 131():804-8. PubMed ID: 20571170
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
    Elliott AM; Luzze H; Quigley MA; Nakiyingi JS; Kyaligonza S; Namujju PB; Ducar C; Ellner JJ; Whitworth JA; Mugerwa R; Johnson JL; Okwera A
    J Infect Dis; 2004 Sep; 190(5):869-78. PubMed ID: 15295690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment].
    Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA
    Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
    Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD4 + T counts with a course of antituberculous therapy in healthy and HIV-infected patients.
    Saenghirunvattana S
    J Med Assoc Thai; 1996 Apr; 79(4):246-8. PubMed ID: 8708511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.